Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126639262 | 12663926 | 2 | F | 201504 | 20160831 | 20160818 | 20160909 | EXP | BR-BAYER-2016-155573 | BAYER | 71.00 | YR | E | F | Y | 0.00000 | 20160909 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126639262 | 12663926 | 1 | PS | NEXAVAR | SORAFENIB | 1 | Oral | 800 MG, QD | Y | 21923 | 800 | MG | FILM-COATED TABLET | QD | |||||
| 126639262 | 12663926 | 2 | SS | NEXAVAR | SORAFENIB | 1 | Oral | 400 MG, QD | Y | 21923 | 400 | MG | FILM-COATED TABLET | QD | |||||
| 126639262 | 12663926 | 3 | SS | NEXAVAR | SORAFENIB | 1 | Oral | 400 MG, QD | Y | 21923 | 400 | MG | FILM-COATED TABLET | QD | |||||
| 126639262 | 12663926 | 4 | C | GLIFAGE | METFORMIN HYDROCHLORIDE | 1 | Oral | 4 DF, HS | 0 | 4 | DF | QD | |||||||
| 126639262 | 12663926 | 5 | C | COMPLEX B | CALCIUM PANTOTHENATECYANOCOBALAMINNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVINTHIAMINE MONONITRATE | 1 | 0 | ||||||||||||
| 126639262 | 12663926 | 6 | C | OMEPRAZOL | OMEPRAZOLE | 1 | Oral | 1 DF, QD | 0 | 1 | DF | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126639262 | 12663926 | 1 | Hepatic cancer |
| 126639262 | 12663926 | 2 | Hepatic cancer |
| 126639262 | 12663926 | 3 | Hepatic cancer |
| 126639262 | 12663926 | 4 | Diabetes mellitus |
| 126639262 | 12663926 | 5 | Decreased appetite |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126639262 | 12663926 | OT |
| 126639262 | 12663926 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126639262 | 12663926 | Abdominal pain | |
| 126639262 | 12663926 | Drug dose omission | |
| 126639262 | 12663926 | Ear swelling | |
| 126639262 | 12663926 | Eye swelling | |
| 126639262 | 12663926 | Generalised erythema | |
| 126639262 | 12663926 | Malaise | |
| 126639262 | 12663926 | Mouth swelling | |
| 126639262 | 12663926 | Pruritus generalised | |
| 126639262 | 12663926 | Rash macular | |
| 126639262 | 12663926 | Skin exfoliation | |
| 126639262 | 12663926 | Somnolence | |
| 126639262 | 12663926 | Swelling face | |
| 126639262 | 12663926 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126639262 | 12663926 | 1 | 201504 | 2015 | 0 | |
| 126639262 | 12663926 | 2 | 20160804 | 201608 | 0 | |
| 126639262 | 12663926 | 3 | 20160807 | 0 |